Trials / Completed
CompletedNCT04732793
To Assess the Safety and Effectiveness of Hyruan ONE Versus a Comparator for the Treatment of Knee Osteoarthritis in Europe
A Prospective, Active Controlled, Randomised, Parallel Group, Double Blind, Multicentre Study to Assess the Safety and Effectiveness of Hyruan ONE Versus a Comparator for the Treatment of Knee Osteoarthritis in Europe
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 284 (actual)
- Sponsor
- LG Chem · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
To Assess the Safety and Effectiveness of Hyruan ONE versus a Comparator for the Treatment of Knee Osteoarthritis in Europe
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hyruan ONE® | For use as a symptomatic treatment of osteoarthritis (OA) of the knee |
| DEVICE | Durolane® | For use as a symptomatic treatment of osteoarthritis (OA) of the knee |
Timeline
- Start date
- 2021-02-03
- Primary completion
- 2021-06-11
- Completion
- 2021-12-07
- First posted
- 2021-02-01
- Last updated
- 2022-03-16
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT04732793. Inclusion in this directory is not an endorsement.